Paul D. Hoeprich

5.7k total citations
171 papers, 4.6k citations indexed

About

Paul D. Hoeprich is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Paul D. Hoeprich has authored 171 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Infectious Diseases, 47 papers in Epidemiology and 44 papers in Molecular Biology. Recurrent topics in Paul D. Hoeprich's work include Antifungal resistance and susceptibility (28 papers), Fungal Infections and Studies (23 papers) and Antimicrobial Resistance in Staphylococcus (17 papers). Paul D. Hoeprich is often cited by papers focused on Antifungal resistance and susceptibility (28 papers), Fungal Infections and Studies (23 papers) and Antimicrobial Resistance in Staphylococcus (17 papers). Paul D. Hoeprich collaborates with scholars based in United States, Switzerland and Japan. Paul D. Hoeprich's co-authors include R. V. F. Lachica, Constantin Genigeorgis, Elliot Goldstein, Ruth M. Lawrence, Craig Blanchette, Patricia D. Finn, George W. Jordan, Richard H. Parker, Gail A. Wong and Brett A. Chromy and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Paul D. Hoeprich

166 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul D. Hoeprich United States 39 1.4k 1.3k 1.2k 443 388 171 4.6k
Victor Fainstein United States 39 1.5k 1.0× 1.6k 1.2× 508 0.4× 349 0.8× 247 0.6× 95 4.1k
Gerald L. Mandell United States 41 1.5k 1.0× 1.7k 1.3× 1.2k 1.1× 450 1.0× 1.2k 3.1× 129 6.0k
James Brunton Canada 40 1.1k 0.8× 2.1k 1.6× 875 0.7× 156 0.4× 699 1.8× 82 4.9k
F. Espersen Denmark 40 1.7k 1.2× 2.1k 1.6× 1.2k 1.0× 740 1.7× 438 1.1× 189 5.3k
John D. Williams United Kingdom 35 1.1k 0.8× 577 0.4× 722 0.6× 235 0.5× 326 0.8× 153 3.9k
Roy L. Hopfer United States 30 1.5k 1.1× 1.7k 1.3× 560 0.5× 386 0.9× 180 0.5× 76 3.3k
Roy T. Steigbigel United States 36 1.8k 1.2× 2.2k 1.6× 621 0.5× 216 0.5× 525 1.4× 75 4.6k
W. Michael Scheld United States 32 2.0k 1.4× 1.6k 1.2× 524 0.4× 239 0.5× 405 1.0× 92 4.6k
Ian R. Poxton United Kingdom 38 1.5k 1.1× 2.1k 1.6× 1.3k 1.1× 356 0.8× 944 2.4× 153 5.1k
Shalom Z. Hirschman United States 31 1.2k 0.8× 751 0.6× 929 0.8× 141 0.3× 502 1.3× 112 3.6k

Countries citing papers authored by Paul D. Hoeprich

Since Specialization
Citations

This map shows the geographic impact of Paul D. Hoeprich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul D. Hoeprich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul D. Hoeprich more than expected).

Fields of papers citing papers by Paul D. Hoeprich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul D. Hoeprich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul D. Hoeprich. The network helps show where Paul D. Hoeprich may publish in the future.

Co-authorship network of co-authors of Paul D. Hoeprich

This figure shows the co-authorship network connecting the top 25 collaborators of Paul D. Hoeprich. A scholar is included among the top collaborators of Paul D. Hoeprich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul D. Hoeprich. Paul D. Hoeprich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Devendra, K., Elizabeth A. Schafer, Thomas G. Burrage, et al.. (2016). Novel 6xHis tagged foot-and-mouth disease virus vaccine bound to nanolipoprotein adjuvant via metal ions provides antigenic distinction and effective protective immunity. Virology. 495. 136–147. 11 indexed citations
2.
Blanchette, Craig, Brent W. Segelke, Nicholas O. Fischer, et al.. (2009). Characterization and Purification of Polydisperse Reconstituted Lipoproteins and Nanolipoprotein Particles. International Journal of Molecular Sciences. 10(7). 2958–2971. 19 indexed citations
3.
Blanchette, Craig, Jenny A. Cappuccio, Edward A. Kuhn, et al.. (2008). Atomic force microscopy differentiates discrete size distributions between membrane protein containing and empty nanolipoprotein particles. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1788(3). 724–731. 35 indexed citations
4.
Nguyen, Thanh‐Son, Paul M.M. Weers, Vincent Raussens, et al.. (2007). Amphotericin B induces interdigitation of apolipoprotein stabilized nanodisk bilayers. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1778(1). 303–312. 22 indexed citations
5.
Hoeprich, Paul D., M. Colin Jordan, & R.N. Allan. (1994). Infectious diseases : a treatise of infectious processes. Lippincott eBooks. 60 indexed citations
6.
Hoeprich, Paul D.. (1992). Clinical Use of Amphotericin B and Derivatives: Lore, Mystique, and Fact. Clinical Infectious Diseases. 14(Supplement_1). S114–S119. 64 indexed citations
7.
Hinthorn, Daniel R., et al.. (1989). Successful treatment of progressive disseminated histoplasmosis with amphotericin B methyl ester. Diagnostic Microbiology and Infectious Disease. 12(1). 17–19. 1 indexed citations
8.
Hoeprich, Paul D.. (1980). Current Principles of Antimicrobic Therapy. Obstetrics and Gynecology. 55(Supplement). 121S–127S. 2 indexed citations
9.
Hoeprich, Paul D.. (1979). The Changing Face of Pneumonia. Hospital Practice. 14(3). 69–77. 1 indexed citations
10.
Lee, KK, et al.. (1979). In Vitro Susceptibilities of Naegleria fowleri Strain HB-1 to Selected Antimicrobial Agents, Singly and in Combination. Antimicrobial Agents and Chemotherapy. 16(2). 217–220. 12 indexed citations
11.
Jordan, George W., Gail A. Wong, & Paul D. Hoeprich. (1976). Bacteriology of the Lower Respiratory Tract as Determined by Fiber-Optic Bronchoscopy and Transtracheal Aspiration. The Journal of Infectious Diseases. 134(5). 428–435. 70 indexed citations
12.
Lawrence, Ruth M. & Paul D. Hoeprich. (1976). Comparison of Amphotericin B and Amphotericin B Methyl Ester: Efficacy in Murine Coccidioidomycosis and Toxicity. The Journal of Infectious Diseases. 133(2). 168–174. 48 indexed citations
13.
Wong, Gail A., T. H. Peirce, Elliot Goldstein, & Paul D. Hoeprich. (1975). Penetration of antimicrobial agents into bronchial secretions. The American Journal of Medicine. 59(2). 219–223. 69 indexed citations
14.
Hoeprich, Paul D.. (1969). Virology Monographs, vol 2.. Archives of Internal Medicine. 123(6). 731–731. 4 indexed citations
15.
Hoeprich, Paul D.. (1967). New Antimicrobics for the Treatment of Infections Caused by Gram-Negative Bacilli. Medical Clinics of North America. 51(5). 1127–1152. 2 indexed citations
16.
Hoeprich, Paul D., et al.. (1964). Polymyxin B and Colistin. New England Journal of Medicine. 270(20). 1030–1035. 82 indexed citations
17.
Hoeprich, Paul D., et al.. (1960). Tellurite reduction as an indicator of potentially pathogenic stapylococci.. PubMed. 55. 120–8. 21 indexed citations
18.
Raab, S. O., Paul D. Hoeprich, M. M. Wintrobe, & George E. Cartwright. (1960). The Clinical Significance of Fever in Acute Leukemia. Blood. 16(5). 1609–1628. 46 indexed citations
19.
Hoeprich, Paul D.. (1957). EVALUATION OF AN IMPROVED CHEMICALLY DEFINED MEDIUM FOR THE CULTURE OF DIPLOCOCCUS PNEUMONIAE. Journal of Bacteriology. 74(5). 587–590. 8 indexed citations
20.
Hoeprich, Paul D.. (1955). C 14 LABELLING OF DIPLOCOCCUS PNEUMONIAE. Journal of Bacteriology. 69(6). 682–688. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Victor Fainstein Breakdown of academic impact, for papers by Gerald L. Mandell Breakdown of academic impact, for papers by James Brunton Breakdown of academic impact, for papers by F. Espersen Breakdown of academic impact, for papers by John D. Williams Breakdown of academic impact, for papers by Roy L. Hopfer Breakdown of academic impact, for papers by Roy T. Steigbigel Breakdown of academic impact, for papers by W. Michael Scheld Breakdown of academic impact, for papers by Ian R. Poxton Breakdown of academic impact, for papers by Shalom Z. Hirschman
Rankless by CCL
2026